|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 10.00 | ACUITE D | Reaffirmed | Issuer not co-operating* | - |
| Total Outstanding | 10.00 | - | - |
| Total Withdrawn | 0.00 | - | - |
| * The issuer did not co-operate; based on best available information. | |||
|
Rating Rationale |
|
Acuité has reaffirmed its long term rating of ‘ACUITE D’ (read as ACUITE D) on the Rs. 10.00 Cr. bank facilities of Ransh Pharma Private Limited (RPPL). The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
| About the Company |
|
Incorporated in 2018, Ransh Pharma Private Limited (RPPL) is a Visakhapatnam based company promoted by Mr. Radha Krishna Talam, Mr. Karri Adi Krishna Rao, Mr. V Nageswar Rao, Mr. K Gowri Sankara Rao, Mr. K Poorna Chandra Rao and Mr. K. Narasinga Rao. RPPL is engaged in manufacturing of bulk drugs and pharmaceutical intermediates and has set up a manufacturing unit of 90 KL in Visakhapatnam, Andhra Pradesh. |
| Unsupported Rating |
| Not Applicable |
| Non-cooperation by the issuer/borrower: |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies. |
| Limitation regarding information availability |
| Rating Sensitivity |
| "No information provided by the issuer / available for Acuite to comment upon." |
| Liquidity Position |
| "No information provided by the issuer / available for Acuite to comment upon." |
| Outlook |
|
Not Applicable |
| Other Factors affecting Rating |
| None |
| Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
| Operating Income | Rs. Cr. | 15.71 | 3.94 |
| PAT | Rs. Cr. | 0.00 | (2.63) |
| PAT Margin | (%) | 0.01 | (66.89) |
| Total Debt/Tangible Net Worth | Times | 5.68 | 4.59 |
| PBDIT/Interest | Times | 2.20 | (1.29) |
| Status of non-cooperation with previous CRA |
|
Not Applicable |
| Any other information |
| None |
| Applicable Criteria |
|
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
| Note on complexity levels of the rated instrument |
|
||||||||||||||||||||
| |
|
|
||||||||||||||||||
|
||||||||||||||||||
| * The issuer did not co-operate; based on best available information. | ||||||||||||||||||
| |
Disclosure of list of non-cooperative issuers |
|
• Listed :- https://www.acuite.in/Non-Cooperative_Issuer_Listed.php • Unlisted :- https://www.acuite.in/Non-Cooperative_Issuer_Unlisted.php |
|
Contacts |
About Acuité Ratings & Research |
| © Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |
